Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
1601
1602
1603
1604
1605
1606
1607
1608
1609
1610
1611
1612
1613
1614
1615
1616
1617
1618
1619
1620
1621
1622
1623
1624
1625
1626
1627
1628
1629
1630
1631
1632
1633
1634
1635
1636
1637
1638
1639
1640
1641
1642
1643
1644
1645
1646
1647
1648
1649
1650
1651
1652
1653
1654
1655
1656
1657
1658
1659
1660
1661
1662
1663
1664
1665
1666
1667
1668
1669
1670
1671
1672
1673
1674
1675
1676
1677
1678
1679
1680
1681
1682
1683
1684
1685
1686
1687
1688
1689
1690
1691
1692
1693
1694
1695
1696
1697
1698
1699
1700
1701
1702
1703
1704
1705
1706
1707
1708
1709
1710
1711
1712
1713
1714
1715
1716
1717
1718
1719
1720
1721
1722
1723
1724
1725
1726
1727
1728
1729
1730
1731
1732
1733
1734
1735
1736
1737
1738
1739
1740
1741
1742
1743
1744
1745
1746
1747
1748
1749
1750
1751
1752
1753
1754
1755
1756
1757
1758
1759
1760
1761
1762
1763
1764
1765
1766
1767
1768
1769
1770
1771
1772
1773
1774
1775
1776
1777
1778
1779
1780
1781
1782
1783
1784
1785
1786
1787
1788
1789
1790
1791
1792
1793
1794
1795
1796
1797
1798
1799
1800
| UnnamedSample_HQ_transcript/15593|m.5582 | UnnamedSample_HQ_transcript/15593 | Identity 0.926 too low. | d80b0e3c2957aace7162c69f6d6d4df1 | 318 | Pfam | PF16086 | Domain of unknown function (DUF4816) | 95 | 134 | 6.2E-13 | T | 22-09-2020 | IPR032134 | Protein of unknown function DUF4816 |
| UnnamedSample_HQ_transcript/100374|m.22695 | UnnamedSample_HQ_transcript/100374 | Unmapped. | 0f64458e785404f4e442895c14d525dc | 240 | Pfam | PF16565 | Phospholipase D-like domain at C-terminus of MIT | 93 | 231 | 1.9E-51 | T | 22-09-2020 | IPR032341 | MIT, C-terminal phospholipase D-like domain |
| UnnamedSample_HQ_transcript/100374|m.22695 | UnnamedSample_HQ_transcript/100374 | Unmapped. | 0f64458e785404f4e442895c14d525dc | 240 | Pfam | PF04212 | MIT (microtubule interacting and transport) domain | 8 | 70 | 4.9E-16 | T | 22-09-2020 | IPR007330 | MIT |
| UnnamedSample_HQ_transcript/46885|m.13338 | UnnamedSample_HQ_transcript/46885 | Coverage 0.087 too low. | 720faaf7c812cab8a09982b949f9d0b1 | 681 | Pfam | PF01590 | GAF domain | 308 | 491 | 7.9E-13 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/46885|m.13338 | UnnamedSample_HQ_transcript/46885 | Coverage 0.087 too low. | 720faaf7c812cab8a09982b949f9d0b1 | 681 | Pfam | PF01590 | GAF domain | 124 | 274 | 6.0E-18 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/46885|m.13338 | UnnamedSample_HQ_transcript/46885 | Coverage 0.087 too low. | 720faaf7c812cab8a09982b949f9d0b1 | 681 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 598 | 680 | 1.5E-33 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/55724|m.15180 | UnnamedSample_HQ_transcript/55724 | Coverage 0.981 too low. | 395f54dcb72a61a3c70fdc9da6bd5be9 | 283 | Pfam | PF04142 | Nucleotide-sugar transporter | 35 | 269 | 1.1E-62 | T | 22-09-2020 | IPR007271 | Nucleotide-sugar transporter |
| UnnamedSample_HQ_transcript/65410|m.17104 | UnnamedSample_HQ_transcript/65410 | Coverage 0.228 too low. | 16f6e746337d64f801d75b9401fb539f | 525 | Pfam | PF00929 | Exonuclease | 360 | 511 | 2.1E-6 | T | 22-09-2020 | IPR013520 | Exonuclease, RNase T/DNA polymerase III |
| UnnamedSample_HQ_transcript/41734|m.12207 | UnnamedSample_HQ_transcript/41734 | Coverage 0.836 too low. | 1000db91cad29411310fdf9abaab67a1 | 371 | Pfam | PF05739 | SNARE domain | 315 | 366 | 2.5E-15 | T | 22-09-2020 | IPR000727 | Target SNARE coiled-coil homology domain |
| UnnamedSample_HQ_transcript/41734|m.12207 | UnnamedSample_HQ_transcript/41734 | Coverage 0.836 too low. | 1000db91cad29411310fdf9abaab67a1 | 371 | Pfam | PF11416 | Syntaxin-5 N-terminal, Sly1p-binding domain | 57 | 73 | 0.002 | T | 22-09-2020 | IPR021538 | Syntaxin-5, N-terminal, Sly1p-binding domain |
| UnnamedSample_HQ_transcript/79182|m.19580 | UnnamedSample_HQ_transcript/79182 | Coverage 0.735 too low. | 1000db91cad29411310fdf9abaab67a1 | 371 | Pfam | PF05739 | SNARE domain | 315 | 366 | 2.5E-15 | T | 22-09-2020 | IPR000727 | Target SNARE coiled-coil homology domain |
| UnnamedSample_HQ_transcript/79182|m.19580 | UnnamedSample_HQ_transcript/79182 | Coverage 0.735 too low. | 1000db91cad29411310fdf9abaab67a1 | 371 | Pfam | PF11416 | Syntaxin-5 N-terminal, Sly1p-binding domain | 57 | 73 | 0.002 | T | 22-09-2020 | IPR021538 | Syntaxin-5, N-terminal, Sly1p-binding domain |
| UnnamedSample_HQ_transcript/68449|m.17658 | UnnamedSample_HQ_transcript/68449 | Coverage 0.749 too low. | 1000db91cad29411310fdf9abaab67a1 | 371 | Pfam | PF05739 | SNARE domain | 315 | 366 | 2.5E-15 | T | 22-09-2020 | IPR000727 | Target SNARE coiled-coil homology domain |
| UnnamedSample_HQ_transcript/68449|m.17658 | UnnamedSample_HQ_transcript/68449 | Coverage 0.749 too low. | 1000db91cad29411310fdf9abaab67a1 | 371 | Pfam | PF11416 | Syntaxin-5 N-terminal, Sly1p-binding domain | 57 | 73 | 0.002 | T | 22-09-2020 | IPR021538 | Syntaxin-5, N-terminal, Sly1p-binding domain |
| UnnamedSample_HQ_transcript/78617|m.19484 | UnnamedSample_HQ_transcript/78617 | Coverage 0.774 too low. | 1000db91cad29411310fdf9abaab67a1 | 371 | Pfam | PF05739 | SNARE domain | 315 | 366 | 2.5E-15 | T | 22-09-2020 | IPR000727 | Target SNARE coiled-coil homology domain |
| UnnamedSample_HQ_transcript/78617|m.19484 | UnnamedSample_HQ_transcript/78617 | Coverage 0.774 too low. | 1000db91cad29411310fdf9abaab67a1 | 371 | Pfam | PF11416 | Syntaxin-5 N-terminal, Sly1p-binding domain | 57 | 73 | 0.002 | T | 22-09-2020 | IPR021538 | Syntaxin-5, N-terminal, Sly1p-binding domain |
| UnnamedSample_HQ_transcript/7550|m.3037 | UnnamedSample_HQ_transcript/7550 | Coverage 0.918 too low. | 05b89448a082f91166432d72fde6a647 | 1337 | Pfam | PF01734 | Patatin-like phospholipase | 935 | 1099 | 3.3E-20 | T | 22-09-2020 | IPR002641 | Patatin-like phospholipase domain |
| UnnamedSample_HQ_transcript/7550|m.3037 | UnnamedSample_HQ_transcript/7550 | Coverage 0.918 too low. | 05b89448a082f91166432d72fde6a647 | 1337 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 493 | 582 | 3.6E-9 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/7550|m.3037 | UnnamedSample_HQ_transcript/7550 | Coverage 0.918 too low. | 05b89448a082f91166432d72fde6a647 | 1337 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 614 | 693 | 4.4E-15 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/7550|m.3037 | UnnamedSample_HQ_transcript/7550 | Coverage 0.918 too low. | 05b89448a082f91166432d72fde6a647 | 1337 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 189 | 282 | 4.6E-11 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/89580|m.21174 | UnnamedSample_HQ_transcript/89580 | Coverage 0.569 too low. | 79bdffb8f5a339d8e360542bc1bb7d52 | 217 | Pfam | PF05091 | Eukaryotic translation initiation factor 3 subunit 7 (eIF-3) | 19 | 162 | 1.2E-29 | T | 22-09-2020 | IPR007783 | Eukaryotic translation initiation factor 3 subunit D |
| UnnamedSample_HQ_transcript/71503|m.18208 | UnnamedSample_HQ_transcript/71503 | Unmapped. | 980b654e73839e316cfe7cc7e6ad3dd3 | 574 | Pfam | PF08762 | CRPV capsid protein like | 465 | 570 | 1.5E-4 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/96437|m.22158 | UnnamedSample_HQ_transcript/96437 | Coverage 0.821 too low. | 90dd0dd38d6ef3345a79b2f1892863e2 | 126 | Pfam | PF04667 | cAMP-regulated phosphoprotein/endosulfine conserved region | 32 | 86 | 7.9E-8 | T | 22-09-2020 | IPR006760 | Endosulphine |
| UnnamedSample_HQ_transcript/121549|m.24962 | UnnamedSample_HQ_transcript/121549 | Identity 0.947 too low. | c1af8e1572f7667ad92e7b1fe1ed1a2b | 123 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 10 | 121 | 1.6E-23 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/24974|m.8215 | UnnamedSample_HQ_transcript/24974 | Coverage 0.054 too low. | 35ff6f3099244a217796139dce01d136 | 770 | Pfam | PF01437 | Plexin repeat | 499 | 530 | 2.1E-6 | T | 22-09-2020 | IPR002165 | Plexin repeat |
| UnnamedSample_HQ_transcript/24974|m.8215 | UnnamedSample_HQ_transcript/24974 | Coverage 0.054 too low. | 35ff6f3099244a217796139dce01d136 | 770 | Pfam | PF01403 | Sema domain | 59 | 470 | 5.1E-130 | T | 22-09-2020 | IPR001627 | Sema domain |
| UnnamedSample_HQ_transcript/39292|m.11708 | UnnamedSample_HQ_transcript/39292 | Coverage 0.292 too low. | cfc9f0b71f6eeb5fc6948eee0f554e2f | 756 | Pfam | PF01431 | Peptidase family M13 | 548 | 752 | 1.1E-54 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/39292|m.11708 | UnnamedSample_HQ_transcript/39292 | Coverage 0.292 too low. | cfc9f0b71f6eeb5fc6948eee0f554e2f | 756 | Pfam | PF05649 | Peptidase family M13 | 61 | 488 | 3.8E-56 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/38214|m.11442 | UnnamedSample_HQ_transcript/38214 | Coverage 0.289 too low. | cfc9f0b71f6eeb5fc6948eee0f554e2f | 756 | Pfam | PF01431 | Peptidase family M13 | 548 | 752 | 1.1E-54 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/38214|m.11442 | UnnamedSample_HQ_transcript/38214 | Coverage 0.289 too low. | cfc9f0b71f6eeb5fc6948eee0f554e2f | 756 | Pfam | PF05649 | Peptidase family M13 | 61 | 488 | 3.8E-56 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/35885|m.10904 | UnnamedSample_HQ_transcript/35885 | Coverage 0.284 too low. | cfc9f0b71f6eeb5fc6948eee0f554e2f | 756 | Pfam | PF01431 | Peptidase family M13 | 548 | 752 | 1.1E-54 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/35885|m.10904 | UnnamedSample_HQ_transcript/35885 | Coverage 0.284 too low. | cfc9f0b71f6eeb5fc6948eee0f554e2f | 756 | Pfam | PF05649 | Peptidase family M13 | 61 | 488 | 3.8E-56 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/31996|m.9947 | UnnamedSample_HQ_transcript/31996 | Coverage 0.266 too low. | cfc9f0b71f6eeb5fc6948eee0f554e2f | 756 | Pfam | PF01431 | Peptidase family M13 | 548 | 752 | 1.1E-54 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/31996|m.9947 | UnnamedSample_HQ_transcript/31996 | Coverage 0.266 too low. | cfc9f0b71f6eeb5fc6948eee0f554e2f | 756 | Pfam | PF05649 | Peptidase family M13 | 61 | 488 | 3.8E-56 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/35252|m.10767 | UnnamedSample_HQ_transcript/35252 | Coverage 0.288 too low. | cfc9f0b71f6eeb5fc6948eee0f554e2f | 756 | Pfam | PF01431 | Peptidase family M13 | 548 | 752 | 1.1E-54 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/35252|m.10767 | UnnamedSample_HQ_transcript/35252 | Coverage 0.288 too low. | cfc9f0b71f6eeb5fc6948eee0f554e2f | 756 | Pfam | PF05649 | Peptidase family M13 | 61 | 488 | 3.8E-56 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/38448|m.11494 | UnnamedSample_HQ_transcript/38448 | Coverage 0.295 too low. | cfc9f0b71f6eeb5fc6948eee0f554e2f | 756 | Pfam | PF01431 | Peptidase family M13 | 548 | 752 | 1.1E-54 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/38448|m.11494 | UnnamedSample_HQ_transcript/38448 | Coverage 0.295 too low. | cfc9f0b71f6eeb5fc6948eee0f554e2f | 756 | Pfam | PF05649 | Peptidase family M13 | 61 | 488 | 3.8E-56 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/62912|m.16611 | UnnamedSample_HQ_transcript/62912 | Identity 0.824 too low. | 129f6857114cb3ccce444b72dda75b04 | 464 | Pfam | PF02172 | KIX domain | 1 | 42 | 4.2E-12 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/87816|m.20909 | UnnamedSample_HQ_transcript/87816 | Identity 0.710 too low. | 129f6857114cb3ccce444b72dda75b04 | 464 | Pfam | PF02172 | KIX domain | 1 | 42 | 4.2E-12 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/8060|m.3211 | UnnamedSample_HQ_transcript/8060 | Coverage 0.784 too low. | de8855ce8d4197345a2eacf3b940a073 | 1376 | Pfam | PF00053 | Laminin EGF domain | 1252 | 1296 | 2.9E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/8060|m.3211 | UnnamedSample_HQ_transcript/8060 | Coverage 0.784 too low. | de8855ce8d4197345a2eacf3b940a073 | 1376 | Pfam | PF00053 | Laminin EGF domain | 3 | 35 | 1.4E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/8060|m.3211 | UnnamedSample_HQ_transcript/8060 | Coverage 0.784 too low. | de8855ce8d4197345a2eacf3b940a073 | 1376 | Pfam | PF00053 | Laminin EGF domain | 1299 | 1338 | 4.4E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/8060|m.3211 | UnnamedSample_HQ_transcript/8060 | Coverage 0.784 too low. | de8855ce8d4197345a2eacf3b940a073 | 1376 | Pfam | PF00053 | Laminin EGF domain | 758 | 806 | 2.0E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/8060|m.3211 | UnnamedSample_HQ_transcript/8060 | Coverage 0.784 too low. | de8855ce8d4197345a2eacf3b940a073 | 1376 | Pfam | PF00053 | Laminin EGF domain | 1044 | 1091 | 4.6E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/8060|m.3211 | UnnamedSample_HQ_transcript/8060 | Coverage 0.784 too low. | de8855ce8d4197345a2eacf3b940a073 | 1376 | Pfam | PF00053 | Laminin EGF domain | 1205 | 1249 | 2.5E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/8060|m.3211 | UnnamedSample_HQ_transcript/8060 | Coverage 0.784 too low. | de8855ce8d4197345a2eacf3b940a073 | 1376 | Pfam | PF00053 | Laminin EGF domain | 1152 | 1202 | 2.8E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/8060|m.3211 | UnnamedSample_HQ_transcript/8060 | Coverage 0.784 too low. | de8855ce8d4197345a2eacf3b940a073 | 1376 | Pfam | PF00053 | Laminin EGF domain | 619 | 667 | 3.9E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/8060|m.3211 | UnnamedSample_HQ_transcript/8060 | Coverage 0.784 too low. | de8855ce8d4197345a2eacf3b940a073 | 1376 | Pfam | PF00053 | Laminin EGF domain | 1010 | 1034 | 1.6E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/8060|m.3211 | UnnamedSample_HQ_transcript/8060 | Coverage 0.784 too low. | de8855ce8d4197345a2eacf3b940a073 | 1376 | Pfam | PF00053 | Laminin EGF domain | 1094 | 1149 | 1.4E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/8060|m.3211 | UnnamedSample_HQ_transcript/8060 | Coverage 0.784 too low. | de8855ce8d4197345a2eacf3b940a073 | 1376 | Pfam | PF00053 | Laminin EGF domain | 38 | 70 | 3.4E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/8060|m.3211 | UnnamedSample_HQ_transcript/8060 | Coverage 0.784 too low. | de8855ce8d4197345a2eacf3b940a073 | 1376 | Pfam | PF00053 | Laminin EGF domain | 710 | 754 | 1.6E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/8060|m.3211 | UnnamedSample_HQ_transcript/8060 | Coverage 0.784 too low. | de8855ce8d4197345a2eacf3b940a073 | 1376 | Pfam | PF00052 | Laminin B (Domain IV) | 874 | 1009 | 6.4E-23 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/16964|m.5996 | UnnamedSample_HQ_transcript/16964 | Unmapped. | b2b54d715038ba85e9536cec7d136198 | 759 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 587 | 753 | 5.2E-10 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/38939|m.11614 | UnnamedSample_HQ_transcript/38939 | Coverage 0.548 too low. | 2f9a36eeeaa49d976e0f38b3e4a3ff94 | 527 | Pfam | PF04831 | Popeye protein conserved region | 93 | 319 | 2.1E-39 | T | 22-09-2020 | IPR006916 | Popeye protein |
| UnnamedSample_HQ_transcript/84761|m.20456 | UnnamedSample_HQ_transcript/84761 | Coverage 0.191 too low. | 7f7f69ca08d450622911f59154f37fa7 | 293 | Pfam | PF10324 | Serpentine type 7TM GPCR chemoreceptor Srw | 32 | 284 | 3.2E-21 | T | 22-09-2020 | IPR019427 | 7TM GPCR, serpentine receptor class w (Srw) |
| UnnamedSample_HQ_transcript/105551|m.23292 | UnnamedSample_HQ_transcript/105551 | Coverage 0.923 too low. | 9f81263bff84fe1747e4586318bd6c06 | 196 | Pfam | PF01553 | Acyltransferase | 3 | 125 | 5.7E-21 | T | 22-09-2020 | IPR002123 | Phospholipid/glycerol acyltransferase |
| UnnamedSample_HQ_transcript/83072|m.20209 | UnnamedSample_HQ_transcript/83072 | Coverage 0.887 too low. | 9bf673e3a9e78b595dccfd3b85de4287 | 445 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 207 | 397 | 1.3E-42 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/83072|m.20209 | UnnamedSample_HQ_transcript/83072 | Coverage 0.887 too low. | 9bf673e3a9e78b595dccfd3b85de4287 | 445 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 88 | 156 | 2.4E-29 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/66890|m.17386 | UnnamedSample_HQ_transcript/66890 | Coverage 0.741 too low. | 9bf673e3a9e78b595dccfd3b85de4287 | 445 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 207 | 397 | 1.3E-42 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/66890|m.17386 | UnnamedSample_HQ_transcript/66890 | Coverage 0.741 too low. | 9bf673e3a9e78b595dccfd3b85de4287 | 445 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 88 | 156 | 2.4E-29 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/71878|m.18281 | UnnamedSample_HQ_transcript/71878 | Coverage 0.968 too low. | d2b192860cde9a9e7b204f8d06853e53 | 496 | Pfam | PF00067 | Cytochrome P450 | 31 | 479 | 1.3E-62 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/93495|m.21734 | UnnamedSample_HQ_transcript/93495 | Coverage 0.615 too low. | 698772780a8acd1e06454ddffbe15b79 | 296 | Pfam | PF00083 | Sugar (and other) transporter | 2 | 275 | 1.4E-43 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/76916|m.19187 | UnnamedSample_HQ_transcript/76916 | Coverage 0.944 too low. | f6572fe08f77f84da1717ef5923a92ea | 508 | Pfam | PF00262 | Calreticulin family | 57 | 430 | 1.8E-148 | T | 22-09-2020 | IPR001580 | Calreticulin/calnexin |
| UnnamedSample_HQ_transcript/86549|m.20727 | UnnamedSample_HQ_transcript/86549 | Coverage 0.877 too low. | d0105a3626f8b036b940f45791a2da38 | 394 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 278 | 365 | 6.2E-15 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/86549|m.20727 | UnnamedSample_HQ_transcript/86549 | Coverage 0.877 too low. | d0105a3626f8b036b940f45791a2da38 | 394 | Pfam | PF00617 | RasGEF domain | 2 | 92 | 2.6E-12 | T | 22-09-2020 | IPR001895 | Ras guanine-nucleotide exchange factors catalytic domain |
| UnnamedSample_HQ_transcript/11930|m.4476 | UnnamedSample_HQ_transcript/11930 | Coverage 0.094 too low. | a190e8f8b91c131fb39ab799a7a5da7c | 1023 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 5 | 72 | 2.4E-21 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/11930|m.4476 | UnnamedSample_HQ_transcript/11930 | Coverage 0.094 too low. | a190e8f8b91c131fb39ab799a7a5da7c | 1023 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 787 | 990 | 5.6E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/11930|m.4476 | UnnamedSample_HQ_transcript/11930 | Coverage 0.094 too low. | a190e8f8b91c131fb39ab799a7a5da7c | 1023 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 350 | 717 | 9.2E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/11930|m.4476 | UnnamedSample_HQ_transcript/11930 | Coverage 0.094 too low. | a190e8f8b91c131fb39ab799a7a5da7c | 1023 | Pfam | PF00122 | E1-E2 ATPase | 126 | 332 | 5.0E-53 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/70500|m.18013 | UnnamedSample_HQ_transcript/70500 | Identity 0.625 too low. | 0c41e5089703fe074584f51f14bbf3af | 265 | Pfam | PF00651 | BTB/POZ domain | 22 | 119 | 5.1E-26 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/13910|m.5084 | UnnamedSample_HQ_transcript/13910 | Coverage 0.104 too low. | 371a9cdec990ef3b21712b77069c23aa | 436 | Pfam | PF00157 | Pou domain - N-terminal to homeobox domain | 224 | 293 | 3.0E-38 | T | 22-09-2020 | IPR000327 | POU-specific domain |
| UnnamedSample_HQ_transcript/13910|m.5084 | UnnamedSample_HQ_transcript/13910 | Coverage 0.104 too low. | 371a9cdec990ef3b21712b77069c23aa | 436 | Pfam | PF00046 | Homeodomain | 312 | 368 | 7.5E-19 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/54027|m.14838 | UnnamedSample_HQ_transcript/54027 | Coverage 0.851 too low. | 7a8b1dfd0b948cdcdaa1cb152c021a28 | 431 | Pfam | PF00168 | C2 domain | 307 | 408 | 5.4E-24 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/54027|m.14838 | UnnamedSample_HQ_transcript/54027 | Coverage 0.851 too low. | 7a8b1dfd0b948cdcdaa1cb152c021a28 | 431 | Pfam | PF00168 | C2 domain | 169 | 266 | 1.3E-21 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/41626|m.12187 | UnnamedSample_HQ_transcript/41626 | Coverage 0.881 too low. | 7a8b1dfd0b948cdcdaa1cb152c021a28 | 431 | Pfam | PF00168 | C2 domain | 307 | 408 | 5.4E-24 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/41626|m.12187 | UnnamedSample_HQ_transcript/41626 | Coverage 0.881 too low. | 7a8b1dfd0b948cdcdaa1cb152c021a28 | 431 | Pfam | PF00168 | C2 domain | 169 | 266 | 1.3E-21 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/15573|m.5576 | UnnamedSample_HQ_transcript/15573 | Coverage 0.501 too low. | c968812f3c744e69e310a1ee734eb338 | 679 | Pfam | PF12017 | Transposase protein | 3 | 202 | 2.1E-13 | T | 22-09-2020 | IPR021896 | Transposase protein |
| UnnamedSample_HQ_transcript/10179|m.3886 | UnnamedSample_HQ_transcript/10179 | Coverage 0.446 too low. | c968812f3c744e69e310a1ee734eb338 | 679 | Pfam | PF12017 | Transposase protein | 3 | 202 | 2.1E-13 | T | 22-09-2020 | IPR021896 | Transposase protein |
| UnnamedSample_HQ_transcript/61712|m.16391 | UnnamedSample_HQ_transcript/61712 | Identity 0.915 too low. | 955140842ff78a4e77c64c2617bfdc0c | 167 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 3 | 146 | 1.0E-38 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/11222|m.4228 | UnnamedSample_HQ_transcript/11222 | Identity 0.947 too low. | 966531f42b9d6370fcbfd27c9313c95d | 1097 | Pfam | PF00567 | Tudor domain | 483 | 604 | 7.9E-19 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/11222|m.4228 | UnnamedSample_HQ_transcript/11222 | Identity 0.947 too low. | 966531f42b9d6370fcbfd27c9313c95d | 1097 | Pfam | PF12872 | OST-HTH/LOTUS domain | 363 | 412 | 0.0022 | T | 22-09-2020 | IPR025605 | OST-HTH/LOTUS domain |
| UnnamedSample_HQ_transcript/11222|m.4228 | UnnamedSample_HQ_transcript/11222 | Identity 0.947 too low. | 966531f42b9d6370fcbfd27c9313c95d | 1097 | Pfam | PF12872 | OST-HTH/LOTUS domain | 279 | 332 | 1.0E-4 | T | 22-09-2020 | IPR025605 | OST-HTH/LOTUS domain |
| UnnamedSample_HQ_transcript/11222|m.4228 | UnnamedSample_HQ_transcript/11222 | Identity 0.947 too low. | 966531f42b9d6370fcbfd27c9313c95d | 1097 | Pfam | PF12872 | OST-HTH/LOTUS domain | 9 | 68 | 1.2E-7 | T | 22-09-2020 | IPR025605 | OST-HTH/LOTUS domain |
| UnnamedSample_HQ_transcript/8257|m.3275 | UnnamedSample_HQ_transcript/8257 | Identity 0.731 too low. | 9b8e8228115b8d5259dabf2fd4f49f85 | 550 | Pfam | PF07679 | Immunoglobulin I-set domain | 331 | 424 | 9.7E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/8257|m.3275 | UnnamedSample_HQ_transcript/8257 | Identity 0.731 too low. | 9b8e8228115b8d5259dabf2fd4f49f85 | 550 | Pfam | PF07679 | Immunoglobulin I-set domain | 442 | 523 | 3.1E-11 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/8257|m.3275 | UnnamedSample_HQ_transcript/8257 | Identity 0.731 too low. | 9b8e8228115b8d5259dabf2fd4f49f85 | 550 | Pfam | PF13927 | Immunoglobulin domain | 21 | 106 | 1.2E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8257|m.3275 | UnnamedSample_HQ_transcript/8257 | Identity 0.731 too low. | 9b8e8228115b8d5259dabf2fd4f49f85 | 550 | Pfam | PF13927 | Immunoglobulin domain | 246 | 312 | 3.8E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/106425|m.23390 | UnnamedSample_HQ_transcript/106425 | Coverage 0.982 too low. | b9806e1d80d3ac939c6d56cd74a665d3 | 202 | Pfam | PF00567 | Tudor domain | 6 | 59 | 1.2E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/4489|m.1995 | UnnamedSample_HQ_transcript/4489 | Coverage 0.139 too low. | 77de5c85a6ed343ad13bfda563309ff4 | 994 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 212 | 386 | 4.0E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/4489|m.1995 | UnnamedSample_HQ_transcript/4489 | Coverage 0.139 too low. | 77de5c85a6ed343ad13bfda563309ff4 | 994 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 64 | 111 | 2.8E-15 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/12011|m.4498 | UnnamedSample_HQ_transcript/12011 | Coverage 0.176 too low. | 77de5c85a6ed343ad13bfda563309ff4 | 994 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 212 | 386 | 4.0E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/12011|m.4498 | UnnamedSample_HQ_transcript/12011 | Coverage 0.176 too low. | 77de5c85a6ed343ad13bfda563309ff4 | 994 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 64 | 111 | 2.8E-15 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/4665|m.2060 | UnnamedSample_HQ_transcript/4665 | Coverage 0.084 too low. | 77de5c85a6ed343ad13bfda563309ff4 | 994 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 212 | 386 | 4.0E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/4665|m.2060 | UnnamedSample_HQ_transcript/4665 | Coverage 0.084 too low. | 77de5c85a6ed343ad13bfda563309ff4 | 994 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 64 | 111 | 2.8E-15 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/19040|m.6592 | UnnamedSample_HQ_transcript/19040 | Coverage 0.725 too low. | 1dc8b47287fa800844a72bc145b59287 | 493 | Pfam | PF01758 | Sodium Bile acid symporter family | 175 | 355 | 1.3E-25 | T | 22-09-2020 | IPR002657 | Bile acid:sodium symporter/arsenical resistance protein Acr3 |
| UnnamedSample_HQ_transcript/59823|m.16023 | UnnamedSample_HQ_transcript/59823 | Unmapped. | e93729629b4e345d7c9c398e3a12f72d | 598 | Pfam | PF00910 | RNA helicase | 242 | 350 | 1.5E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/81012|m.19885 | UnnamedSample_HQ_transcript/81012 | Coverage 0.414 too low. | ba1e73b53b0d93518e31dfc58c385e3c | 360 | Pfam | PF00089 | Trypsin | 201 | 324 | 7.4E-25 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/81012|m.19885 | UnnamedSample_HQ_transcript/81012 | Coverage 0.414 too low. | ba1e73b53b0d93518e31dfc58c385e3c | 360 | Pfam | PF16030 | Serine protease gd N-terminus | 24 | 130 | 3.1E-16 | T | 22-09-2020 | IPR031986 | Serine protease gd, N-terminal domain |
| UnnamedSample_HQ_transcript/85840|m.20629 | UnnamedSample_HQ_transcript/85840 | Coverage 0.314 too low. | 0df2ff6666a49610f5a4a85d9899d502 | 434 | Pfam | PF02181 | Formin Homology 2 Domain | 1 | 102 | 1.8E-15 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/18474|m.6440 | UnnamedSample_HQ_transcript/18474 | Coverage 0.968 too low. | 15d6ceb2f63ac6db2819b0845218d844 | 1097 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 657 | 1096 | 1.1E-120 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/18474|m.6440 | UnnamedSample_HQ_transcript/18474 | Coverage 0.968 too low. | 15d6ceb2f63ac6db2819b0845218d844 | 1097 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 20 | 164 | 1.2E-15 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/18474|m.6440 | UnnamedSample_HQ_transcript/18474 | Coverage 0.968 too low. | 15d6ceb2f63ac6db2819b0845218d844 | 1097 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 512 | 655 | 7.4E-48 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/18474|m.6440 | UnnamedSample_HQ_transcript/18474 | Coverage 0.968 too low. | 15d6ceb2f63ac6db2819b0845218d844 | 1097 | Pfam | PF00204 | DNA gyrase B | 207 | 367 | 5.2E-26 | T | 22-09-2020 | IPR013506 | DNA topoisomerase, type IIA, subunit B, domain 2 |
| UnnamedSample_HQ_transcript/18474|m.6440 | UnnamedSample_HQ_transcript/18474 | Coverage 0.968 too low. | 15d6ceb2f63ac6db2819b0845218d844 | 1097 | Pfam | PF01751 | Toprim domain | 396 | 497 | 5.8E-8 | T | 22-09-2020 | IPR006171 | TOPRIM domain |
| UnnamedSample_HQ_transcript/4576|m.2025 | UnnamedSample_HQ_transcript/4576 | Unmapped. | 2049cd40237fc8b607941fba6d399179 | 503 | Pfam | PF17222 | Viral cysteine endopeptidase C107 | 164 | 396 | 6.9E-11 | T | 22-09-2020 | IPR033777 | Viral cysteine endopeptidase C107 |
| UnnamedSample_HQ_transcript/250|m.214 | UnnamedSample_HQ_transcript/250 | Unmapped. | 89d8fdfd635d5ddcb95036fcd0089e11 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/205|m.182 | UnnamedSample_HQ_transcript/205 | Unmapped. | 89d8fdfd635d5ddcb95036fcd0089e11 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/244|m.209 | UnnamedSample_HQ_transcript/244 | Unmapped. | 89d8fdfd635d5ddcb95036fcd0089e11 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/220|m.194 | UnnamedSample_HQ_transcript/220 | Unmapped. | 89d8fdfd635d5ddcb95036fcd0089e11 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/850|m.565 | UnnamedSample_HQ_transcript/850 | Unmapped. | 89d8fdfd635d5ddcb95036fcd0089e11 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/21161|m.7187 | UnnamedSample_HQ_transcript/21161 | Coverage 0.169 too low. | b4c6cea9946ac190505adaa7cd6007ba | 302 | Pfam | PF00501 | AMP-binding enzyme | 32 | 276 | 5.7E-43 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/16619|m.5898 | UnnamedSample_HQ_transcript/16619 | Coverage 0.634 too low. | b6b49c46483e3e18f9c379802fea15fd | 1030 | Pfam | PF00570 | HRDC domain | 608 | 673 | 1.9E-14 | T | 22-09-2020 | IPR002121 | HRDC domain |
| UnnamedSample_HQ_transcript/16619|m.5898 | UnnamedSample_HQ_transcript/16619 | Coverage 0.634 too low. | b6b49c46483e3e18f9c379802fea15fd | 1030 | Pfam | PF09382 | RQC domain | 452 | 526 | 6.0E-8 | T | 22-09-2020 | IPR018982 | RQC domain |
| UnnamedSample_HQ_transcript/16619|m.5898 | UnnamedSample_HQ_transcript/16619 | Coverage 0.634 too low. | b6b49c46483e3e18f9c379802fea15fd | 1030 | Pfam | PF00271 | Helicase conserved C-terminal domain | 262 | 357 | 2.0E-19 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/16619|m.5898 | UnnamedSample_HQ_transcript/16619 | Coverage 0.634 too low. | b6b49c46483e3e18f9c379802fea15fd | 1030 | Pfam | PF16124 | RecQ zinc-binding | 370 | 437 | 5.4E-10 | T | 22-09-2020 | IPR032284 | ATP-dependent DNA helicase RecQ, zinc-binding domain |
| UnnamedSample_HQ_transcript/16619|m.5898 | UnnamedSample_HQ_transcript/16619 | Coverage 0.634 too low. | b6b49c46483e3e18f9c379802fea15fd | 1030 | Pfam | PF00270 | DEAD/DEAH box helicase | 45 | 207 | 4.9E-15 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/17592|m.6189 | UnnamedSample_HQ_transcript/17592 | Coverage 0.627 too low. | b6b49c46483e3e18f9c379802fea15fd | 1030 | Pfam | PF00570 | HRDC domain | 608 | 673 | 1.9E-14 | T | 22-09-2020 | IPR002121 | HRDC domain |
| UnnamedSample_HQ_transcript/17592|m.6189 | UnnamedSample_HQ_transcript/17592 | Coverage 0.627 too low. | b6b49c46483e3e18f9c379802fea15fd | 1030 | Pfam | PF09382 | RQC domain | 452 | 526 | 6.0E-8 | T | 22-09-2020 | IPR018982 | RQC domain |
| UnnamedSample_HQ_transcript/17592|m.6189 | UnnamedSample_HQ_transcript/17592 | Coverage 0.627 too low. | b6b49c46483e3e18f9c379802fea15fd | 1030 | Pfam | PF00271 | Helicase conserved C-terminal domain | 262 | 357 | 2.0E-19 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/17592|m.6189 | UnnamedSample_HQ_transcript/17592 | Coverage 0.627 too low. | b6b49c46483e3e18f9c379802fea15fd | 1030 | Pfam | PF16124 | RecQ zinc-binding | 370 | 437 | 5.4E-10 | T | 22-09-2020 | IPR032284 | ATP-dependent DNA helicase RecQ, zinc-binding domain |
| UnnamedSample_HQ_transcript/17592|m.6189 | UnnamedSample_HQ_transcript/17592 | Coverage 0.627 too low. | b6b49c46483e3e18f9c379802fea15fd | 1030 | Pfam | PF00270 | DEAD/DEAH box helicase | 45 | 207 | 4.9E-15 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/40059|m.11856 | UnnamedSample_HQ_transcript/40059 | Coverage 0.874 too low. | 19aaa09703b258265a733461e8623c66 | 556 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 42 | 110 | 8.6E-6 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/40059|m.11856 | UnnamedSample_HQ_transcript/40059 | Coverage 0.874 too low. | 19aaa09703b258265a733461e8623c66 | 556 | Pfam | PF00013 | KH domain | 466 | 535 | 4.2E-17 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/40059|m.11856 | UnnamedSample_HQ_transcript/40059 | Coverage 0.874 too low. | 19aaa09703b258265a733461e8623c66 | 556 | Pfam | PF00013 | KH domain | 146 | 210 | 2.6E-16 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/40059|m.11856 | UnnamedSample_HQ_transcript/40059 | Coverage 0.874 too low. | 19aaa09703b258265a733461e8623c66 | 556 | Pfam | PF00013 | KH domain | 385 | 448 | 2.3E-14 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/40059|m.11856 | UnnamedSample_HQ_transcript/40059 | Coverage 0.874 too low. | 19aaa09703b258265a733461e8623c66 | 556 | Pfam | PF00013 | KH domain | 226 | 292 | 9.6E-15 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/6646|m.2760 | UnnamedSample_HQ_transcript/6646 | Coverage 0.659 too low. | 2ab8bd5f9798bf0d58aaf398dd173799 | 747 | Pfam | PF18101 | Pan3 Pseudokinase domain | 590 | 726 | 3.4E-43 | T | 22-09-2020 | IPR041332 | Pan3 pseudokinase domain |
| UnnamedSample_HQ_transcript/6828|m.2807 | UnnamedSample_HQ_transcript/6828 | Coverage 0.679 too low. | 2ab8bd5f9798bf0d58aaf398dd173799 | 747 | Pfam | PF18101 | Pan3 Pseudokinase domain | 590 | 726 | 3.4E-43 | T | 22-09-2020 | IPR041332 | Pan3 pseudokinase domain |
| UnnamedSample_HQ_transcript/7368|m.2974 | UnnamedSample_HQ_transcript/7368 | Coverage 0.682 too low. | 2ab8bd5f9798bf0d58aaf398dd173799 | 747 | Pfam | PF18101 | Pan3 Pseudokinase domain | 590 | 726 | 3.4E-43 | T | 22-09-2020 | IPR041332 | Pan3 pseudokinase domain |
| UnnamedSample_HQ_transcript/4789|m.2110 | UnnamedSample_HQ_transcript/4789 | Coverage 0.391 too low. | da7b95c043be3d1e7f3cd8e7a9876010 | 599 | Pfam | PF00225 | Kinesin motor domain | 66 | 394 | 2.9E-119 | T | 22-09-2020 | IPR001752 | Kinesin motor domain |
| UnnamedSample_HQ_transcript/93115|m.21682 | UnnamedSample_HQ_transcript/93115 | Coverage 0.081 too low. | 6b80b6f5cb67d442accf131167d02d1b | 296 | Pfam | PF00067 | Cytochrome P450 | 17 | 292 | 1.0E-59 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/15472|m.5541 | UnnamedSample_HQ_transcript/15472 | Coverage 0.440 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF05033 | Pre-SET motif | 723 | 835 | 3.9E-15 | T | 22-09-2020 | IPR007728 | Pre-SET domain |
| UnnamedSample_HQ_transcript/15472|m.5541 | UnnamedSample_HQ_transcript/15472 | Coverage 0.440 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF00856 | SET domain | 854 | 1068 | 4.2E-28 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/15472|m.5541 | UnnamedSample_HQ_transcript/15472 | Coverage 0.440 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF01429 | Methyl-CpG binding domain | 651 | 701 | 6.4E-5 | T | 22-09-2020 | IPR001739 | Methyl-CpG DNA binding |
| UnnamedSample_HQ_transcript/15472|m.5541 | UnnamedSample_HQ_transcript/15472 | Coverage 0.440 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF18359 | Histone methyltransferase Tudor domain 1 | 384 | 437 | 2.0E-22 | T | 22-09-2020 | IPR041291 | Histone methyltransferase, Tudor domain 1 |
| UnnamedSample_HQ_transcript/15472|m.5541 | UnnamedSample_HQ_transcript/15472 | Coverage 0.440 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF18358 | Histone methyltransferase Tudor domain | 476 | 525 | 2.1E-20 | T | 22-09-2020 | IPR041292 | Histone methyltransferase, Tudor domain 2 |
| UnnamedSample_HQ_transcript/15692|m.5611 | UnnamedSample_HQ_transcript/15692 | Coverage 0.428 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF05033 | Pre-SET motif | 723 | 835 | 3.9E-15 | T | 22-09-2020 | IPR007728 | Pre-SET domain |
| UnnamedSample_HQ_transcript/15692|m.5611 | UnnamedSample_HQ_transcript/15692 | Coverage 0.428 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF00856 | SET domain | 854 | 1068 | 4.2E-28 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/15692|m.5611 | UnnamedSample_HQ_transcript/15692 | Coverage 0.428 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF01429 | Methyl-CpG binding domain | 651 | 701 | 6.4E-5 | T | 22-09-2020 | IPR001739 | Methyl-CpG DNA binding |
| UnnamedSample_HQ_transcript/15692|m.5611 | UnnamedSample_HQ_transcript/15692 | Coverage 0.428 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF18359 | Histone methyltransferase Tudor domain 1 | 384 | 437 | 2.0E-22 | T | 22-09-2020 | IPR041291 | Histone methyltransferase, Tudor domain 1 |
| UnnamedSample_HQ_transcript/15692|m.5611 | UnnamedSample_HQ_transcript/15692 | Coverage 0.428 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF18358 | Histone methyltransferase Tudor domain | 476 | 525 | 2.1E-20 | T | 22-09-2020 | IPR041292 | Histone methyltransferase, Tudor domain 2 |
| UnnamedSample_HQ_transcript/17421|m.6131 | UnnamedSample_HQ_transcript/17421 | Coverage 0.445 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF05033 | Pre-SET motif | 723 | 835 | 3.9E-15 | T | 22-09-2020 | IPR007728 | Pre-SET domain |
| UnnamedSample_HQ_transcript/17421|m.6131 | UnnamedSample_HQ_transcript/17421 | Coverage 0.445 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF00856 | SET domain | 854 | 1068 | 4.2E-28 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/17421|m.6131 | UnnamedSample_HQ_transcript/17421 | Coverage 0.445 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF01429 | Methyl-CpG binding domain | 651 | 701 | 6.4E-5 | T | 22-09-2020 | IPR001739 | Methyl-CpG DNA binding |
| UnnamedSample_HQ_transcript/17421|m.6131 | UnnamedSample_HQ_transcript/17421 | Coverage 0.445 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF18359 | Histone methyltransferase Tudor domain 1 | 384 | 437 | 2.0E-22 | T | 22-09-2020 | IPR041291 | Histone methyltransferase, Tudor domain 1 |
| UnnamedSample_HQ_transcript/17421|m.6131 | UnnamedSample_HQ_transcript/17421 | Coverage 0.445 too low. | 2ce473b6a62141fab492da35f7245956 | 1093 | Pfam | PF18358 | Histone methyltransferase Tudor domain | 476 | 525 | 2.1E-20 | T | 22-09-2020 | IPR041292 | Histone methyltransferase, Tudor domain 2 |
| UnnamedSample_HQ_transcript/15681|m.5609 | UnnamedSample_HQ_transcript/15681 | Coverage 0.091 too low. | 89cf18a08eb558414c1404ddc7f463c2 | 593 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 474 | 536 | 1.2E-8 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/15681|m.5609 | UnnamedSample_HQ_transcript/15681 | Coverage 0.091 too low. | 89cf18a08eb558414c1404ddc7f463c2 | 593 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 313 | 375 | 5.0E-8 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/15681|m.5609 | UnnamedSample_HQ_transcript/15681 | Coverage 0.091 too low. | 89cf18a08eb558414c1404ddc7f463c2 | 593 | Pfam | PF12901 | SUZ-C motif | 557 | 580 | 3.4E-5 | T | 22-09-2020 | IPR024642 | SUZ-C domain |
| UnnamedSample_HQ_transcript/36751|m.11103 | UnnamedSample_HQ_transcript/36751 | Identity 0.915 too low. | 716f4aef0db49675d9e8ddfa39c71044 | 456 | Pfam | PF06031 | SERTA motif | 191 | 225 | 3.0E-15 | T | 22-09-2020 | IPR009263 | SERTA domain |
| UnnamedSample_HQ_transcript/29502|m.9356 | UnnamedSample_HQ_transcript/29502 | Identity 0.924 too low. | 716f4aef0db49675d9e8ddfa39c71044 | 456 | Pfam | PF06031 | SERTA motif | 191 | 225 | 3.0E-15 | T | 22-09-2020 | IPR009263 | SERTA domain |
| UnnamedSample_HQ_transcript/35538|m.10830 | UnnamedSample_HQ_transcript/35538 | Identity 0.918 too low. | 716f4aef0db49675d9e8ddfa39c71044 | 456 | Pfam | PF06031 | SERTA motif | 191 | 225 | 3.0E-15 | T | 22-09-2020 | IPR009263 | SERTA domain |
| UnnamedSample_HQ_transcript/16553|m.5874 | UnnamedSample_HQ_transcript/16553 | Identity 0.949 too low. | 716f4aef0db49675d9e8ddfa39c71044 | 456 | Pfam | PF06031 | SERTA motif | 191 | 225 | 3.0E-15 | T | 22-09-2020 | IPR009263 | SERTA domain |
| UnnamedSample_HQ_transcript/32140|m.9988 | UnnamedSample_HQ_transcript/32140 | Identity 0.921 too low. | 716f4aef0db49675d9e8ddfa39c71044 | 456 | Pfam | PF06031 | SERTA motif | 191 | 225 | 3.0E-15 | T | 22-09-2020 | IPR009263 | SERTA domain |
| UnnamedSample_HQ_transcript/26727|m.8657 | UnnamedSample_HQ_transcript/26727 | Identity 0.927 too low. | 716f4aef0db49675d9e8ddfa39c71044 | 456 | Pfam | PF06031 | SERTA motif | 191 | 225 | 3.0E-15 | T | 22-09-2020 | IPR009263 | SERTA domain |
| UnnamedSample_HQ_transcript/29107|m.9257 | UnnamedSample_HQ_transcript/29107 | Identity 0.935 too low. | 716f4aef0db49675d9e8ddfa39c71044 | 456 | Pfam | PF06031 | SERTA motif | 191 | 225 | 3.0E-15 | T | 22-09-2020 | IPR009263 | SERTA domain |
| UnnamedSample_HQ_transcript/48941|m.13784 | UnnamedSample_HQ_transcript/48941 | Coverage 0.177 too low. | cb324bd42a3ac095d291c9921d391421 | 424 | Pfam | PF03022 | Major royal jelly protein | 123 | 400 | 1.6E-76 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/40174|m.11878 | UnnamedSample_HQ_transcript/40174 | Coverage 0.261 too low. | cb324bd42a3ac095d291c9921d391421 | 424 | Pfam | PF03022 | Major royal jelly protein | 123 | 400 | 1.6E-76 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/31388|m.9809 | UnnamedSample_HQ_transcript/31388 | Coverage 0.325 too low. | cb324bd42a3ac095d291c9921d391421 | 424 | Pfam | PF03022 | Major royal jelly protein | 123 | 400 | 1.6E-76 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/35752|m.10870 | UnnamedSample_HQ_transcript/35752 | Coverage 0.294 too low. | cb324bd42a3ac095d291c9921d391421 | 424 | Pfam | PF03022 | Major royal jelly protein | 123 | 400 | 1.6E-76 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/40659|m.11997 | UnnamedSample_HQ_transcript/40659 | Coverage 0.640 too low. | ef173f7a943e171440bba6ffb68beddd | 546 | Pfam | PF00012 | Hsp70 protein | 1 | 408 | 1.1E-69 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/15757|m.5629 | UnnamedSample_HQ_transcript/15757 | Unmapped. | 79237235b7b31b60a985447d41943230 | 1067 | Pfam | PF08762 | CRPV capsid protein like | 887 | 1038 | 2.1E-9 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/20053|m.6884 | UnnamedSample_HQ_transcript/20053 | Unmapped. | 79237235b7b31b60a985447d41943230 | 1067 | Pfam | PF08762 | CRPV capsid protein like | 887 | 1038 | 2.1E-9 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/10157|m.3878 | UnnamedSample_HQ_transcript/10157 | Coverage 0.817 too low. | 678cbcd374987f9a8a166a706220f814 | 852 | Pfam | PF00168 | C2 domain | 699 | 801 | 1.8E-13 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/105887|m.23323 | UnnamedSample_HQ_transcript/105887 | Coverage 0.931 too low. | 5227a89cd898b2d24a33384c6f5e28c1 | 281 | Pfam | PF00170 | bZIP transcription factor | 242 | 280 | 1.5E-11 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/98828|m.22472 | UnnamedSample_HQ_transcript/98828 | Coverage 0.941 too low. | 825b07a0093eb6d3174d8b5b3db4cd26 | 330 | Pfam | PF04561 | RNA polymerase Rpb2, domain 2 | 201 | 323 | 1.6E-27 | T | 22-09-2020 | IPR007642 | RNA polymerase Rpb2, domain 2 |
| UnnamedSample_HQ_transcript/98828|m.22472 | UnnamedSample_HQ_transcript/98828 | Coverage 0.941 too low. | 825b07a0093eb6d3174d8b5b3db4cd26 | 330 | Pfam | PF04563 | RNA polymerase beta subunit | 38 | 200 | 7.5E-59 | T | 22-09-2020 | IPR007644 | RNA polymerase, beta subunit, protrusion |
| UnnamedSample_HQ_transcript/2362|m.1193 | UnnamedSample_HQ_transcript/2362 | Coverage 0.255 too low. | 6644a9251eadeac9018313810e3972d3 | 1066 | Pfam | PF16212 | Phospholipid-translocating P-type ATPase C-terminal | 827 | 1028 | 6.1E-68 | T | 22-09-2020 | IPR032630 | P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/2362|m.1193 | UnnamedSample_HQ_transcript/2362 | Coverage 0.255 too low. | 6644a9251eadeac9018313810e3972d3 | 1066 | Pfam | PF13246 | Cation transport ATPase (P-type) | 490 | 580 | 3.7E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/2362|m.1193 | UnnamedSample_HQ_transcript/2362 | Coverage 0.255 too low. | 6644a9251eadeac9018313810e3972d3 | 1066 | Pfam | PF16209 | Phospholipid-translocating ATPase N-terminal | 41 | 101 | 3.3E-25 | T | 22-09-2020 | IPR032631 | P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/16700|m.5917 | UnnamedSample_HQ_transcript/16700 | Coverage 0.972 too low. | 1a9a1ca5d7c21626719cd2c27f640a11 | 537 | Pfam | PF07679 | Immunoglobulin I-set domain | 71 | 146 | 3.2E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/16700|m.5917 | UnnamedSample_HQ_transcript/16700 | Coverage 0.972 too low. | 1a9a1ca5d7c21626719cd2c27f640a11 | 537 | Pfam | PF07679 | Immunoglobulin I-set domain | 374 | 461 | 7.1E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/16700|m.5917 | UnnamedSample_HQ_transcript/16700 | Coverage 0.972 too low. | 1a9a1ca5d7c21626719cd2c27f640a11 | 537 | Pfam | PF07679 | Immunoglobulin I-set domain | 277 | 364 | 2.3E-19 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/16700|m.5917 | UnnamedSample_HQ_transcript/16700 | Coverage 0.972 too low. | 1a9a1ca5d7c21626719cd2c27f640a11 | 537 | Pfam | PF00047 | Immunoglobulin domain | 187 | 261 | 1.3E-11 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/121542|m.24960 | UnnamedSample_HQ_transcript/121542 | Coverage 0.983 too low. | e0e5802ff0e7b02bfb8343bf73440d8e | 132 | Pfam | PF00505 | HMG (high mobility group) box | 72 | 132 | 8.2E-16 | T | 22-09-2020 | IPR009071 | High mobility group box domain |
| UnnamedSample_HQ_transcript/84849|m.20473 | UnnamedSample_HQ_transcript/84849 | Coverage 0.972 too low. | 0c3ad5c6b32ea6bc91e428bd0c981d61 | 392 | Pfam | PF01851 | Proteasome/cyclosome repeat | 32 | 66 | 9.9E-9 | T | 22-09-2020 | IPR002015 | Proteasome/cyclosome repeat |
| UnnamedSample_HQ_transcript/84849|m.20473 | UnnamedSample_HQ_transcript/84849 | Coverage 0.972 too low. | 0c3ad5c6b32ea6bc91e428bd0c981d61 | 392 | Pfam | PF18004 | 26S proteasome regulatory subunit RPN2 C-terminal domain | 167 | 359 | 1.2E-43 | T | 22-09-2020 | IPR040623 | 26S proteasome regulatory subunit RPN2, C-terminal |
| UnnamedSample_HQ_transcript/95077|m.21967 | UnnamedSample_HQ_transcript/95077 | Coverage 0.356 too low. | 95479f3967718fa513417c8101396280 | 393 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 3 | 393 | 3.1E-62 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 33 | 87 | 3.0E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 795 | 850 | 1.2E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 451 | 506 | 8.0E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 604 | 662 | 4.7E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 637 | 693 | 6.2E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 344 | 401 | 1.8E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 736 | 793 | 2.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 485 | 543 | 3.4E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 549 | 605 | 5.8E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 130 | 185 | 5.5E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 2 | 56 | 2.4E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 88 | 143 | 1.0E-6 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 308 | 366 | 1.3E-6 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4104|m.1843 | UnnamedSample_HQ_transcript/4104 | Coverage 0.836 too low. | 90ff8a17991a8925374b91087e1097e2 | 925 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 860 | 914 | 1.4E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/119963|m.24846 | UnnamedSample_HQ_transcript/119963 | Coverage 0.980 too low. | d344c1fd963dd6e0ffd8e23d8f029c0b | 179 | Pfam | PF00611 | Fes/CIP4, and EFC/F-BAR homology domain | 2 | 47 | 2.9E-7 | T | 22-09-2020 | IPR001060 | FCH domain |
| UnnamedSample_HQ_transcript/15431|m.5531 | UnnamedSample_HQ_transcript/15431 | Coverage 0.690 too low. | f3e827042d24c152f9df298c80c26980 | 844 | Pfam | PF00595 | PDZ domain | 748 | 829 | 2.2E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/2496|m.1232 | UnnamedSample_HQ_transcript/2496 | Coverage 0.062 too low. | 8010bbff387e07652d11db9bbf5af0a0 | 1314 | Pfam | PF14843 | Growth factor receptor domain IV | 732 | 839 | 4.3E-14 | T | 22-09-2020 | IPR032778 | Growth factor receptor domain 4 |
| UnnamedSample_HQ_transcript/2496|m.1232 | UnnamedSample_HQ_transcript/2496 | Coverage 0.062 too low. | 8010bbff387e07652d11db9bbf5af0a0 | 1314 | Pfam | PF16470 | Peptidase S8 pro-domain | 45 | 121 | 4.9E-25 | T | 22-09-2020 | IPR032815 | Peptidase S8, pro-domain |
| UnnamedSample_HQ_transcript/2496|m.1232 | UnnamedSample_HQ_transcript/2496 | Coverage 0.062 too low. | 8010bbff387e07652d11db9bbf5af0a0 | 1314 | Pfam | PF00082 | Subtilase family | 195 | 484 | 5.5E-39 | T | 22-09-2020 | IPR000209 | Peptidase S8/S53 domain |
| UnnamedSample_HQ_transcript/2496|m.1232 | UnnamedSample_HQ_transcript/2496 | Coverage 0.062 too low. | 8010bbff387e07652d11db9bbf5af0a0 | 1314 | Pfam | PF01483 | Proprotein convertase P-domain | 545 | 633 | 1.1E-25 | T | 22-09-2020 | IPR002884 | P domain |
| UnnamedSample_HQ_transcript/30813|m.9661 | UnnamedSample_HQ_transcript/30813 | Identity 0.922 too low. | 3152f01128b756501502f087df1ab8b8 | 743 | Pfam | PF08337 | Plexin cytoplasmic RasGAP domain | 432 | 735 | 2.0E-95 | T | 22-09-2020 | IPR013548 | Plexin, cytoplasmic RasGAP domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
